Medinotec Inc 's ROA from the first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Medinotec Inc 's ROA in the first quarter of 2026?
Medinotec Inc achieved a return on average assets (ROA) of 11.76 % in its first quarter of 2026, which is below Medinotec Inc 's average return on assets, which stands at 14.22%.

ROA has improved compared to 11.65% in the fourth quarter of 2026, due to net income growth.

However, within the Healthcare sector 73 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the fourth quarter of 2026 from 140 to 517.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(May 31 2026) I. Quarter	(Feb 28 2026) IV. Quarter	(Nov 30 2025) III. Quarter	(Aug 31 2025) II. Quarter	(May 31 2025) I. Quarter
Y / Y Total Assets Change	46.43 %	0.42 %	40.95 %	19.84 %	70.56 %
Y / Y Net Income Change	95.12 %	-	30 %	21.71 %	30.48 %
Net Income (TTM) in million	1	1	2	2	2
Return On Assets (TTM)	11.76 %	11.65 %	34.35 %	35.55 %	36.07 %
MDNC's Total Ranking	# 517	# 140	# 125	# 115	# 108
Total Assets (TTM) in million	11	7	7	6	7
Seq. Total Assets Change	58.75 %	0.42 %	6.7 %	-13.91 %	8.87 %
Seq. Net Income Change	-	-	16.4 %	204.58 %	-92.3 %

MDNC's 5 Years Annual ROA >> Back to MDNC Management Effectiveness >> Compare MDNC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 18
Sector	# 74
Overall	# 416

Return On Assets Statistics
High	Average	Low
40.68 %	14.22 %	-10.28 %
(Feb 28 2025)		(Feb 29 2024)

Financial Statements
Medinotec Inc 's Assets	$ 11 million	MDNC's Balance sheet
Medinotec Inc 's Income	$ 0 million	Quarterly MDNC's Income Statement
MDNC's Income by Division		See MDNC's Income by Division

Annual Return On Assets	(Feb 28 2026) FY 2026	(Feb 28 2025) FY 2025	(Feb 29 2024) FY 2024	(Feb 28 2023) FY 2023	FY
Y / Y Total Assets Change	0.42 %	40.95 %	78.52 %	-	-
Total Assets in million	7	7	5	3	0
Y / Y Net Income Change	-63.21 %	-	-	-	-
Net Income in million	1	2	0	0	0
Annual Return On Assets	11.68 %	31.89 %	-8.42 %	-13.11 %	-

MDNC's 5 Years Annual ROA >> Back to MDNC Management Effectiveness >> Compare MDNC ROA to its Competitors

Comment on MDNC's ROA in the fiscal year ending 2026

In the fiscal year 2026 Medinotec Inc 's ROA decreased compared to previous year to 11.68 %, due to deterioration of net income -63.21 % to $0.79 million, from $2.16 million a year ago, as MDNC's assets were $6.80 million.

More Return On Assets Ratios
MDNC's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MDNC's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MDNC's Competitors
Subscribers only: Roa for Medinotec Inc 's Suppliers
Subscribers only: Return On Assets for MDNC's Customers

You may also want to know
MDNC's Roi	MDNC's Inventory Turnover Ratio	MDNC's Growth Rates	MDNC's Dividend Comparisons
	MDNC's Profitability Ratios	MDNC's Asset Turnover Ratio	MDNC's Dividend Growth
MDNC's Roe	MDNC's Valuation Ratios	MDNC's Financial Strength Ratios	MDNC's Dividend Payout Ratio

Companies with similar Return On Assets at May 31 2026, within Healthcare Sector	ROA
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %
Dexcom Inc	14.87 %
Neurocrine Biosciences Inc	14.73 %
Entera Bio Ltd	14.60 %

Date modified: 2026-07-10T05:52:43+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.